Home Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.8, p.601–603, 2019

Journal info


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.2


Aims and Scope
Editorial Info
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.120, No.8, p.601–603, 2019

Title: The effect of GnRH agonists on angiogenesis and its implications for the myocardium in patients with cardiac risk
Author: Z. Valaskova, I. Hulin, O. El Hassoun, S. Polak, B. Mladosievicova

Abstract: Gonadotropin-releasing hormone agonists were described as anti-angiogenic factors in tumors. Simultaneously they were associated with increased cardiovascular risk in patients treated for prostate cancer, especially in those with preexisting cardiac disease. Studies aiming to elucidate the mechanisms by which androgen deprivation therapy causes cardiovascular effects are rare. We believe that gonadotropin-releasing hormone agonists can impair myocardial angiogenesis. That, in patients with myocardial disease can deepen hypoxia, significantly worsen the condition of the myocardium, and therefore increase the risk of cardiac failure. Careful assessment of the myocardial status and consequent timing and typing of therapy can minimalize the adverse effects. Ideally through close cooperation between cardiologists and oncologists (Fig. 1, Ref. 25).

Keywords: angiogenesis, cardiovascular risk, follicle stimulating hormone, GnRH agonist, testosterone
Published online: 29-Jul-2019
Year: 2019, Volume: 120, Issue: 8 Page From: 601, Page To: 603

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.